Annual Changes to the Nasdaq Biotechnology Index
In This Article:
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq Biotechnology Index (Nasdaq: NBI), which will become effective prior to market open on Monday, December 21, 2020.
The Index is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® (Nasdaq®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB).
The following 100 securities will be added to the Index:
| EXCHANGE | SYMBOL | COMPANY NAME |
| Nasdaq | ABUS | Arbutus Biopharma Corporation |
| Nasdaq | ADAP | Adaptimmune Therapeutics plc |
| Nasdaq | AKUS | Akouos, Inc. |
| Nasdaq | ALT | Altimmune, Inc. |
| Nasdaq | ALVR | AlloVir, Inc. |
| Nasdaq | ALXO | ALX Oncology Holdings Inc. |
| Nasdaq | AMTI | Applied Molecular Transport Inc. |
| Nasdaq | ANNX | Annexon, Inc. |
| Nasdaq | APLT | Applied Therapeutics, Inc. |
| Nasdaq | APRE | Aprea Therapeutics, Inc. |
| Nasdaq | ARCT | Arcturus Therapeutics Holdings Inc. |
| Nasdaq | ARQT | Arcutis Biotherapeutics, Inc. |
| Nasdaq | AVDL | Avadel Pharmaceuticals plc |
| Nasdaq | AZN | AstraZeneca PLC |
| Nasdaq | BDTX | Black Diamond Therapeutics, Inc. |
| Nasdaq | BEAM | Beam Therapeutics Inc. |
| Nasdaq | BNTX | BioNTech SE |
| Nasdaq | CABA | Cabaletta Bio, Inc. |
| Nasdaq | CALA | Calithera Biosciences, Inc. |
| Nasdaq | CDXS | Codexis, Inc. |
| Nasdaq | CLVS | Clovis Oncology, Inc. |
| Nasdaq | CNCE | Concert Pharmaceuticals, Inc. |
| Nasdaq | CNST | Constellation Pharmaceuticals, Inc. |
| Nasdaq | CRNX | Crinetics Pharmaceuticals, Inc. |
| Nasdaq | CRTX | Cortexyme, Inc. |
| Nasdaq | FMTX | Forma Therapeutics Holdings, Inc. |
| Nasdaq | FPRX | Five Prime Therapeutics, Inc. |
| Nasdaq | FREQ | Frequency Therapeutics, Inc. |
| Nasdaq | FULC | Fulcrum Therapeutics, Inc. |
| Nasdaq | FUSN | Fusion Pharmaceuticals Inc. |
| Nasdaq | GBIO | Generation Bio Co. |
| Nasdaq | GMDA | Gamida Cell Ltd. |
| Nasdaq | HARP | Harpoon Therapeutics, Inc. |
| Nasdaq | IDYA | IDEAYA Biosciences, Inc. |
| Nasdaq | IGMS | IGM Biosciences, Inc. |
| Nasdaq | IMAB | I-MAB |
| Nasdaq | IMUX | Immunic, Inc. |
| Nasdaq | IMVT | Immunovant, Inc. |
| Nasdaq | INZY | Inozyme Pharma, Inc. |
| Nasdaq | ISEE | IVERIC bio, Inc. |
| Nasdaq | ITOS | iTeos Therapeutics, Inc. |
| Nasdaq | JNCE | Jounce Therapeutics, Inc. |
| Nasdaq | KALA | Kala Pharmaceuticals, Inc. |
| Nasdaq | KALV | KalVista Pharmaceuticals, Inc. |
| Nasdaq | KDMN | Kadmon Holdings, Inc. |
| Nasdaq | KDNY | Chinook Therapeutics, Inc. |
| Nasdaq | KLDO | Kaleido Biosciences, Inc. |
| Nasdaq | KMDA | Kamada Ltd. |
| Nasdaq | KNSA | Kiniksa Pharmaceuticals, Ltd. |
| Nasdaq | KROS | Keros Therapeutics, Inc. |
| Nasdaq | KRYS | Krystal Biotech, Inc. |
| Nasdaq | KZR | Kezar Life Sciences, Inc. |
| Nasdaq | LEGN | Legend Biotech Corporation |
| Nasdaq | LRMR | Larimar Therapeutics, Inc. |
| Nasdaq | MDGL | Madrigal Pharmaceuticals, Inc. |
| Nasdaq | MNOV | MediciNova, Inc. |
| Nasdaq | MRNS | Marinus Pharmaceuticals, Inc. |
| Nasdaq | MRSN | Mersana Therapeutics, Inc. |
| Nasdaq | NK | NantKwest, Inc. |
| Nasdaq | NKTX | Nkarta, Inc. |
| Nasdaq | NLTX | Neoleukin Therapeutics, Inc. |
| Nasdaq | NRIX | Nurix Therapeutics, Inc. |
| Nasdaq | NVAX | Novavax, Inc. |
| Nasdaq | NXTC | NextCure, Inc. |
| Nasdaq | OCUL | Ocular Therapeutix, Inc. |
| Nasdaq | ODT | Odonate Therapeutics, Inc. |
| Nasdaq | ORIC | Oric Pharmaceuticals, Inc. |
| Nasdaq | OVID | Ovid Therapeutics Inc. |
| Nasdaq | PAHC | Phibro Animal Health Corporation |
| Nasdaq | PAND | Pandion Therapeutics Inc. |
| Nasdaq | PASG | Passage Bio, Inc. |
| Nasdaq | PCVX | Vaxcyte, Inc. |
| Nasdaq | PLRX | Pliant Therapeutics, Inc. |
| Nasdaq | PRTK | Paratek Pharmaceuticals, Inc. |
| Nasdaq | PRVB | Provention Bio, Inc. |
| Nasdaq | PSTX | Poseida Therapeutics, Inc. |
| Nasdaq | RAPT | RAPT Therapeutics, Inc. |
| Nasdaq | RDHL | Redhill Biopharma Ltd. |
| Nasdaq | REPL | Replimune Group, Inc. |
| Nasdaq | RLAY | Relay Therapeutics, Inc. |
| Nasdaq | RLMD | Relmada Therapeutics, Inc. |
| Nasdaq | RNA | Avidity Biosciences, Inc. |
| Nasdaq | RPRX | Royalty Pharma plc |
| Nasdaq | RPTX | Repare Therapeutics Inc. |
| Nasdaq | RVMD | Revolution Medicines, Inc. |
| Nasdaq | SELB | Selecta Biosciences, Inc. |
| Nasdaq | SMMT | Summit Therapeutics Inc. |
| Nasdaq | SNDX | Syndax Pharmaceuticals, Inc. |
| Nasdaq | SPRO | Spero Therapeutics, Inc. |
| Nasdaq | STRO | Sutro Biopharma, Inc. |
| Nasdaq | SURF | Surface Oncology, Inc. |
| Nasdaq | SWTX | SpringWorks Therapeutics, Inc. |
| Nasdaq | TCRR | TCR2 Therapeutics Inc. |
| Nasdaq | VIE | Viela Bio, Inc. |
| Nasdaq | VIR | Vir Biotechnology, Inc. |
| Nasdaq | VSTM | Verastem, Inc. |
| Nasdaq | VYNE | VYNE Therapeutics Inc. |
| Nasdaq | XENE | Xenon Pharmaceuticals Inc. |
| Nasdaq | ZIOP | ZIOPHARM Oncology Inc |
| Nasdaq | ZNTL | Zentalis Pharmaceuticals, Inc. |
As a result of the reconstitution, the following 16 securities will be removed from the Index: